We describe a case of hypercalcaemia secondary to recurrent malignant phaeochromocytoma. Parathyroid-related protein (PTHrp 1-86) immunoreactivity was identified in plasma and PTHrp was identified by immunocytochemistry in tumour tissue.
ing obstructive uropathy including reports ofpelvic extramedullary erythropoiesis among the nonthalassaemic disorders. 79 The cortical irregularity and coarsening of the trabecular pattern of the lumbosacral spines as shown in the CT scan suggested that the extramedullary erythropoiesis in our patient represented extrusion of proliferating marrow through the cortex rather than embolization of circulating totipotential cells as was proposed by AskUpmark.9 In the previous study of the CT features of presacral extramedullary erythropoiesis masses in thalassaemias, irregularity and erosion of the anterior cortex of the sacrum were also observed.4 '6 In order to decompress the erythropoietic mass, radiation is often the treatment ofchoice' since the mass is highly radiosensitive and surgical intervention may result in massive haemorrhage due to the high vasculature of the tumour."1 Issaragrisil et al.
reported a prompt response of the mass with spinal cord compression to deep X-ray therapy at a dose of 2,000-3,000 rad.'2 The erythropoietic mass in our patient however did not respond satisfactorily to radiation. The relatively huge mass and hypoxic autoinfarction, as demonstrated by Tc-99m sulphur colloid marrow image, could be responsible for this radiotolerant effect,'3 and early surgical decompression should be considered in such cases.
Introduction
The association of phaeochromocytoma with hypercalcaemia is infrequent but well documented, and usually (although not always) occurs [1] [2] [3] [4] [5] , serum 1, 25-OH vitamin D 15 ng/ml (reference range 3-30), calcitonin 0.08 jtg/ml (reference range < 0.08) and myeloma screen were negative. Plasma PTHrp 1-86, measured by a sensitive two-site immunometric assay, was raised (0.7 pmol/l (reference range <0.25)). One month following treatment with pamidronate, the serum calcium began to rise again (calcium 2.82 mmol/l, albumin 36 g/1) but not to levels requiring further treatment.
Although the para-aortic mass was felt most likely to be a recurrent phaeochromocytoma, it was difficult to prove it. The patient was normotensive off antihypertensive treatment, urinary VMA values were only borderline, the MIBG scan was normal and a CT-guided needle biopsy of the para-aortic mass did not yield a histological diagnosis. Laparotomy, however, revealed malignant para-aortic lymphadenopathy, the histology of which was phaeochromocytoma, very similar to histology obtained 8 years earlier. Immunohistochemical staining of the laparotomy tumour specimen using a rabbit antiserum to PTHrp 37 -67 was positive.
Only immediately preoperatively (and postoperatively), did he become hypertensive requiring intravenous labetalol. Plasma noradrenaline (12.6 pmol/ml (0.5 -3.5)) and urinary VMA (70 pmol/24 hours (9-36)) was elevated but plasma adrenaline remained normal -characteristic of a non-adrenal source of catecholamine. Blood pressure returned to normal without treatment 5 days later. He subsequently died of bronchopneumonia one month following laparotomy.
Discussion
This case illustrates several interesting aspects of phaeochromocytoma. Long-term recurrence is well described up to 30 years but continues to surprise. Recurrence as a malignant tumour is less common and has a less favourable prognosis. Episodic hypertension is described as commonly as 50%9 and in our patient was only present immediately pre-and post-operatively. This hypertension was easily controlled with relatively small doses of labetalol. Presentation with hypercalcaemia is uncommon but well described, although only in non-malignant cases. Serum and tissue identification of PTHrp makes it likely that PTHrp was the cause of hypercalcaemia in this patient.
